Graham Capital Management »

Lyell Immunopharma shares owned by Graham Capital Management

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Graham Capital Management from 13F filings

Historical chart of Graham Capital Management investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by Graham Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by Graham Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $163k 12k 14.05

More positions owned by Graham Capital Management

Ishares Tr Russell 2000 Etf (IWM)
Vaneck Etf Trust Gold Miners Etf (GDX)
Gamestop Corp Note 6/1 (Principal)
Penguin Solutions Note 2.000% 8/1 (Principal)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Applied Digital Corp Note 2.750% 6/0 (Principal)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Green Plains Note 5.250%11/0 (Principal)
Amazon (AMZN)
Groupon Note 4.875% 6/3 (Principal)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Rivian Automotive Note 3.625%10/1 (Principal)
Calumet Put Option (CLMT)
Sunrun Note 4.000% 3/0 (Principal)

View all positions for Graham Capital Management

Top funds holding Lyell Immunopharma

Arch Venture Corp
GSK
Vanguard Capital Management
Orland Properties
BlackRock
Almitas Capital
Foresite Capital Management V
Millennium Management
Opaleye Management
venBio Partners
Geode Capital Management
Alphabet
Sc China Holding
Renaissance Technologies
Northern Trust

View all funds holding Lyell Immunopharma